Boehringer Ingelheim
DOJ
False Claims Act
Anti Kickback
Obstruction
Penalty
$95 million
Outcome
Boehringer Ingelheim to Pay $95 Million<br /> <br /> to Resolve False Claims Act Allegations
Details
Boehringer Ingelheim — DOJ Enforcement (2012)
DOJ took enforcement action against Boehringer Ingelheim in CT in 2012 involving false claims act, anti kickback, obstruction violations in the Independent Pharmacies sector.
Penalty: $95 million
Violation types: False Claims Act, Anti Kickback, Obstruction
Entity type: Pharmacy
Penalty type: Settlement
Location: CT
Source: DOJ Press Release — Boehringer Ingelheim to Pay $95 Million
to Resolve False Claims Act Allegations
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works